Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Condition:   Chronic Myeloid Leukemia Intervention:   Other: Nilotinib Sponsor:   Novartis Pharmaceuticals Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials